Find the most effective statistical approach for your compound’s trial
Berry Consultants are experts at identifying the approach best suited for your trial compound, based on decades of experience of designing and running trials at all phases of clinical development.
Depending on the indication, the clinical context, and the presence or absence of existing data for the compound, there are a wide range of possible designs to support a smarter trial than the traditional alternatives.
The analysis can be Bayesian, or frequentist, modeled or model-free, and you can choose from ambitious designs where the trial can stop early or transition to a different clinical phase, or a more cautious approach that merely alters the randomization ratios between treatment groups based on incoming data.
Improve your drug development decisions
Once you have chosen a statistical approach for your trial, our trial simulation and modeling services can help you understand the likely outcome of the trial across a range of situations, making sure that your trial maximizes the information obtained from each patient, and optimizes the drug development decisions.
Subscribe to the Tessella Berry Consultants FACTS™ software service to simulate and model a range of fixed and adaptive trial designs such as continuous re-assessment method, first-in-man trials, and Bayesian dose-finding making sure that you have the best trial design possible.
More information about FACTS
For some trials we create unique software for our design and analysis projects. The ability to design new software for your needs makes us ideally suited to tackle the toughest and most challenging biostatistical problems.
Berry Consultants have appeared before many regulatory groups with, and on behalf of, medical device and pharmaceutical clients seeking approval for their trial designs. All Tessella Berry software has been thoroughly validated and documented.